LGALS3 and ankylosing spondylitis: Previous studies documented the changed levels of galectin-3 in patients with RA, juvenile idiopathic arthritis (JIA), SSc, ankylosing spondylitis (AS), or Behcet’s diseases (BD) [6,21,22,23,24].